Literature DB >> 3158705

Regulation and deregulation of the fluid-phase classical pathway C3 convertase.

I Gigli, J Sorvillo, L Halbwachs-Mecarelli.   

Abstract

Three mechanisms that regulate the formation and function of the fluid-phase classical pathway C3 convertase (C4b2a) have been elucidated: a) a temperature-mediated intrinsic decay of the enzyme; b) an extrinsic accelerated decay mediated by the effect of the serum protein C4b-binding protein (C4-bp); and c) the inactivation of C4b in the C4b-C4b-p complex by the proteolytic action of C3b/C4b inactivator (I), which cleaves the alpha 1-chain of C4b yielding C4d (alpha 2-chain), and C4c (alpha 3-, alpha 4-, beta-, gamma-chains). A fourth mechanism is described based on the observation that the IgG fraction of the serum of certain patients with glomerulonephritis contains a protein that prevents the intrinsic and C4-bp-mediated decay of surface-bound C4b2a. This protein prolongs the half-life of fluid-phase C4b2a from 10 min to more than 5 hr, increasing the utilization of C3. It also inhibits the decay mediated by C4-bp by preventing the dissociation of C2a from the C4b, 2a complex. In addition, I alone or in the presence of C4-bp fails to cleave the alpha 1-chain of C4b in the stabilized C4b, 2a complex. This protective property of the stabilizing factor (NFc) requires the presence of C2a because C4b was not protected unless it was bound to C2a. Therefore, NFc provides a mechanism by which the serum regulatory proteins are bypassed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158705

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.

Authors:  T Meri; S J Cutler; A M Blom; S Meri; T S Jokiranta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.

Authors:  Y Tanuma; H Ohi; S Watanabe; M Seki; M Hatano
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).

Authors:  Nenoo Rawal; Rema Rajagopalan; Veena P Salvi
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

4.  The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.

Authors:  T Meri; A M Blom; A Hartmann; D Lenk; S Meri; P F Zipfel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion.

Authors:  Shanshan Luo; Anna M Blom; Steffen Rupp; Uta-Christina Hipler; Bernhard Hube; Christine Skerka; Peter F Zipfel
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

6.  Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).

Authors:  H Ohi; T Yasugi
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).

Authors:  H Ohi; S Watanabe; T Fujita; T Yasugi
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 8.  Complement components and their autoantibodies.

Authors:  P Norsworthy; K A Davies
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.860

9.  Pasteurella pneumotropica evades the human complement system by acquisition of the complement regulators factor H and C4BP.

Authors:  Alfredo Sahagún-Ruiz; Adriana Patricia Granados Martinez; Leandro Carvalho Dantas Breda; Tatiana Rodrigues Fraga; Mónica Marcela Castiblanco Valencia; Angela Silva Barbosa; Lourdes Isaac
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.